STACY SHARPE: Open Payments
NPI 1720330285 · WEST BLOOMFIELD, MI. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$3,344 in 118 payments from 17 companies in 2025. Trend: 2023 $1,393 · 2024 $2,685 · 2025 $3,344
Food & beverage: $3,336Education: $8
| Company | Payments | Amount |
|---|---|---|
| Vanda Pharmaceuticals Inc. | 23 | $827 |
| Axsome Therapeutics, Inc. | 14 | $432 |
| Lundbeck LLC | 10 | $325 |
| ABBVIE INC. | 19 | $310 |
| Neurocrine BioSciences, Inc. | 12 | $307 |
| Collegium Pharmaceutical, Inc. | 7 | $218 |
| ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) | 4 | $186 |
| Tris Pharma Inc | 5 | $183 |
| Otsuka America Pharmaceutical, Inc. | 10 | $182 |
| Supernus Pharmaceuticals, Inc. | 3 | $141 |
Products named: HETLIOZ, Auvelity, REXULTI, INGREZZA, VRAYLAR, Jornay PM, FANAPT, CAPLYTA.
Industry payments across MI — which companies pay providers there.
